Page not found

Search results

  1. Dr. James Crowe Jr. receives SEC Faculty Achievement Award

    ... have helped propel Vanderbilt’s role on the world stage in the development of treatments against COVID-19 and other devastating ... cited papers in leading scientific journals, including  Cell ,  Science  and in major medical journals such as  NEJM  and  ...

    sommers - 04/12/2021 - 10:53am

  2. ASPIRE - Technology Commercialization - Session 4

    ... fields of work. This session will cover an overview of technology commercialization, including academic commercialization strategies, role of translational research, and early stage product development. As part of a federal grant, it is requested that ...

    utleytj - 10/02/2015 - 10:45am

  3. Tech Connect, Vol. 6, Issue 16: CTTC participates at AUTM 2016

    ... participates at AUTM 2016 Each year, thousands of technology transfer officers convene with professionals from a variety of ... partnering meetings with companies with interests in early stage university inventions.  ...

    steelmk - 11/10/2016 - 7:45am

  4. Monoclonal antibody “cocktail” blocks COVID-19 variants: study

    ... University School of Medicine in St. Louis. In cell-culture studies, the researchers determined the ability of monoclonal ... Microbiology and Immunology at Vanderbilt. “We chose two antibodies to create a mixture that specifically would resist escape by ...

    sommers - 03/08/2021 - 8:39am

  5. VUMC-led team isolates antibody that blocks bird flu

    ... transmitted from birds to humans. In the journal  Cell Host & Microbe , James Crowe Jr., MD, and colleagues report that human monoclonal antibodies, isolated from two survivors of H7N9 infections and produced in bulk in the laboratory, ...

    sommers - 12/16/2019 - 10:57am

  6. A protein that can melt tumors discovered at Vanderbilt

    ... gene expression programs through interaction with Host Cell Factor-1,” was  published  in the journal  eLIFE  on Jan. 8.  ... activate genes. Protein transcription factors only need two domains: a DNA binding domain and an activation domain that spurs DNA ...

    sommers - 02/01/2021 - 10:02am

  7. New tool may speed antibody, vaccine research

    ... and validation of LIBRA-seq, which stands for Linking B-cell Receptor to Antigen Specificity through sequencing, was described recently ... The team is hopeful that LIBRA-seq will be a transformative technology that will have a direct impact on both basic and applied research. ...

    sommers - 12/16/2019 - 3:04pm

  8. Vanderbilt biochemists reveal the cause of Charcot-Marie-Tooth disease

    ... dexterity and the sense of touch in the hands and feet. Over two decades, Sanders has been studying a targeted approach to treat ... a protein that snakes through the lipid bilayer of the cell several times until it reaches the cell surface. Under disease conditions, ...

    sommers - 10/30/2020 - 12:43pm

  9. Widely used software, developed by Young Lab, tops 1,000 academic licenses

    ... understand metabolic diseases or improve the productivity of cell-based bioprocesses.  “We developed it to serve our own research ... said Masood Ahammed Machingal, manager, digital technology licensing Building on the successes of non-patented intellectual ...

    sommers - 05/03/2021 - 10:24am

  10. PinPtr and VenoStent win the NSF Accelerating Innovation Research - Technology Translation Grant

    09/10/2015 Two Vanderbilt technologies, PinPtr (high-precision, low-cost GPS cloud ... Science Foundation Accelerating Innovation Research - Technology Translation (AIR-TT) grant of approximately $200,000 (each). PinPtr ... The AIR-TT solicitation supports research to overcome technology barriers/knowledge gaps in the translation of NSF-funded fundamental ...

    steelmk - 10/02/2015 - 10:45am